Literature DB >> 1791853

A DNA sequence for the discrimination of Neisseria gonorrhoeae from other Neisseria species.

C G Miyada1, T L Born.   

Abstract

A 350 base pair Neisseria gonorrhoeae DNA restriction fragment was cloned after subtractive hybridization to Neisseria meningitidis DNA. This restriction fragment hybridized to 105 out of 106 N. gonorrhoeae strains tested. While three N. meningitidis strains did not hybridize to this probe, Neisseria mucosa DNA exhibited cross-hybridization. This particular clone was used to screen a N. gonorrhoeae genomic DNA library. A positive 2.4 kilobase pair clone was shown by DNA sequencing to contain two long open reading frames. One open reading frame did not hybridize to N. mucosa and other Neisseria species, while it retained specificity for the original 105 N gonorrhoeae strains. This open reading frame also showed significant homology to cytosine DNA methyltransferases.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1791853     DOI: 10.1016/s0890-8508(06)80003-4

Source DB:  PubMed          Journal:  Mol Cell Probes        ISSN: 0890-8508            Impact factor:   2.365


  3 in total

1.  Enhancing the specificity of the COBAS AMPLICOR CT/NG test for Neisseria gonorrhoeae by retesting specimens with equivocal results.

Authors:  B Van Der Pol; D H Martin; J Schachter; T C Quinn; C A Gaydos; R B Jones; K Crotchfelt; J Moncada; D Jungkind; B Turner; C Peyton; J F Kelly; J B Weiss; M Rosenstraus
Journal:  J Clin Microbiol       Date:  2001-09       Impact factor: 5.948

2.  Evaluation of the Abbott RealTime CT/NG assay in comparison to the Roche Cobas Amplicor CT/NG assay.

Authors:  Annie Cheng; Qinfang Qian; James E Kirby
Journal:  J Clin Microbiol       Date:  2011-02-16       Impact factor: 5.948

3.  The diagnosis of chlamydia, gonorrhoea, and trichomonas infections by self obtained low vaginal swabs, in remote northern Australian clinical practice.

Authors:  S C Garrow; D W Smith; G B Harnett
Journal:  Sex Transm Infect       Date:  2002-08       Impact factor: 3.519

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.